A number of bis(benzyl)polyamine analogs were found to be potent inhibitors ofboth chloroquine-resistant and chloroquine-sensitive strains of the human malaria parasite Plasmodiumfalciparum in vitro (IC50 values = 0.2-14MM).
Malaria remains one of the most important human infectious diseases in the world. Resistance of Plasmodiumfalciparum to chloroquine and other antimalarial drugs has created an urgent need for new drugs that are effective against resistant strains (1) . Radical departure from the chemical classes of compounds effective in the past is needed to circumvent the problems of cross-resistance between drugs. We have studied an approach to the chemotherapy of malaria that involves the disruption of the biosynthesis and/or intracellular function of the polyamines-putrescine, spermidine, and spermine.
The polyamines are important regulators of growth and differentiation in a wide variety of cell types including parasitic protozoa (2) . a-Difluoromethylomithine (DFMO; eflornithine), an irreversible inhibitor of the first enzyme in polyamine biosynthesis, ornithine decarboxylase, inhibits the proliferation of a number of human-infective parasites, including P. falciparum (3, 4) . We have recently shown that DFMO also inhibits the growth of Plasmodium berghei in mice but does not cure these infections (5) .
Another approach to interference with polyamine biosynthesis and function, which has been applied successfully in cancer cells (6) , takes advantage of the ability of the natural polyamines (7, 8) and nonphysiological polyamine analogs (9, 10) to suppress ornithine decarboxylase activity in the cell and also possibly to block the intracellular function of the natural polyamines by displacing them from critical binding sites, such as appear to be present on DNA (11) . In this approach, it is preferred that the polyamine analogs not subserve the normal physiological roles of putrescine, spermidine, and spermine, because then they would simply replace the natural polyamines and growth inhibition would not occur. We now report on a series of bis(benzyl)polyamine analogs that have marked antimalarial activity against both chloroquine-sensitive and chloroquine-resistant P. falciparum in vitro and, when administered in combination with DFMO, cure murine malaria.
MATERIALS AND METHODS Culture of P. falciparum. P. falciparum [clone D6 of the Sierra Leone strain (12) and strain FCR-3/Gambia from June M. Whaun (Walter Reed Army Institute of Research), which was originally described by Jensen and Trager (13) ] was maintained in continuous culture in human erythrocytes by the method of Trager and Jensen (14) . Maintenance cultures, in 25-cm2 flasks at 370C, contained a 6% suspension of human (type 0+) erythrocytes in RPMI 1640 medium supplemented with 10% human serum, 25 mM Hepes, and 0.2% NaHCO3 with a gaseous phase of 90% N2/5% 02/5% CO2. Cultures were fed daily with fresh medium and were subcultured twice weekly by 10-to 20-fold dilutions with fresh human erythrocytes.
Microtiter Cultures for Drug Testing. Drug testing in vitro was carried out using standard procedures (15) . In the 96-well microtiter cultures P.falciparum (FCR-3/Gambia strain) was at a starting parasitemia of =0.5% in a 1% suspension of erythrocytes in a total volume of 0.2 ml. Test compounds were dissolved directly in culture medium and then filtersterilized.
[3H]Hypoxanthine ( amine kit, GIBCO). Incorporation of the tritium-labeled compounds was determined as above using an automatic cell harvester.
To determine whether the effects of MDL 27695 were specifically on the synthesis of either DNA or RNA, or both, parasitized erythrocytes were labeled with [3H]hypoxanthine, washed with cold culture medium, and lysed with a solution of 50 mM Tris-HCl (pH 7.0) containing 10 mM EDTA, 2% Triton X-100 (vol/vol), and 10 ,g of calf thymus DNA per ml. Total nucleic acids were extracted with trichloroacetic acid as described (17) . RNA was digested by incubating the pellet of total nucleic acids with 0.3 M NaOH for 18 hr at 37°C. The remaining DNA was again precipitated with trichloroacetic acid, and the radioactivity incorporated into DNA and total nucleic acids was measured by collecting the precipitates on glass fiber filters followed by scintillation counting. Radioactive incorporation into RNA was determined by subtracting the radioactivity present in DNA from that present in the total nucleic acids.
P. berghei Infections. The P. berghei infection model used to study the blood schizonticidal activity of our compounds was that of Peters et al. (18) . Outbred CD-1 mice (Charles River Breeding Laboratories) weighing [20] [21] [22] Degrees of parasitemia were determined using thin smears of venous blood stained with Giemsa. Results are expressed as the percentage of erythrocytes infected with at least one parasite.
Chemicals. [ by =50% (5). Table 3 shows that treatment with MDL 27695 alone (group 2) resulted in a 70% suppression of parasitemia by day 4 and a 21% cure rate (3/14) , whereas the combination of MDL 27695 (15 mg/kg) and 2% DFMO (group 3) resulted in a 95% suppression of parasitemia on day 4 and a 100% cure rate (14/14) . In a second experiment MDL 27695 (15 mg/kg) plus 2% DFMO (group 6) again suppressed parasitemia by 95% by day 4 and gave a 90% cure rate (18/20) . Lowering the dose Mice were infected and treated following the outlined standard protocol. Mice were considered cured when they were aparasitemic on periodic examination and lived for >4 months after infection. MDL 27695 was administered i.p., whereas DFMO was given in drinking water. The average day of death is calculated based only on the animals that died. Exp., experiment.
of MDL 27695 to 10 mg/kg (group 5) resulted in less suppression of parasitemia (83%) and only a 75% cure rate (15/20) . Overall, 47/54 (87%) mice were cured in two separate experiments with MDL 27695 at 10 or 15 mg/kg plus 2% DFMO. Mice cured in these experiments were rechallenged with P. berghei 4 months after the initial infection, and although parasitemia developed, it was transient, suggesting that immunity had developed. It was next found that MDL 27695 plus DFMO was also an effective combination against severe "established" infections of P. berghei in mice (Table 4) . Mice were allowed to develop a high parasitemia over a 7-day period before beginning drug treatments. All mice appeared moribund when drug treatments commenced. Subsequent treatment with MDL 27695 plus DFMO over a 2-week period resulted in cures for 15/15 animals that finished the full course of chemotherapy. Five mice in the drug-treated group, all of which had parasitemias in excess of 40% at the time drug treatment began, died during the first 2 days of treatment of infections.
DISCUSSION
The bis(benzyl)polyamine analogs we have described herein were markedly cytotoxic to malaria parasites in vitro and in vivo. The growth inhibitory activity of the analogs against P. falciparum in vitro increased as the length of the central methylene chain (Table 1) was lengthened from 4 to 12. The increasing potency appears to be related to the lipid solubilities of the analogs and, therefore, possibly to the uptake of the compound into the host erythrocytes. In line with this hypothesis is the finding that free-amine analogs, which are much more water soluble, were at least 1000 times less potent against P. falciparum than their bis(benzyl) counterparts. In preliminary studies conducted in our laboratories, the bis-(benzyl) analogs were accumulated by human erythrocytes to a much greater extent than were the free-amine analogs (data not shown). Ready access to the intraerythrocytic compartment may, in part, explain why the polyamine analog MDL 27695 was also effective against P. berghei in mice.
The first biochemical effect of MDL 27695 that we have noted in P. falciparum was inhibition of RNA and DNA synthesis within 3-6 hr after addition of the analog. The depression in DNA/RNA synthesis preceded by several hours the inhibition of [3H]isoleucine incorporation into proteins. These data lead us to propose that one mechanism for destruction of malaria parasites by polyamine analogs is relatively rapid inhibition of macromolecular synthesis leading to cell death. The analogs may bind to DNA in a manner similar to the natural polyamines (19) , or the compounds may act as bifunctional intercalating agents, such as the diacridine polyamine analogs described by Canellakis et al. (20) . The mechanism of action of the diacridine polyamines was found to be specific inhibition of RNA synthesis, purportedly through direct interaction with DNA (21, 22) .
Binding of the polyamine analogs to DNA is also an attractive explanation for the apparent potentiation by DFMO of the effects of MDL 27695 in vivo. It was shown previously that depletion of polyamines by DFMO sensitized tumor cells to the cytocidal effects of drugs thought to act through binding to DNA (23) . It was also shown that the addition of DFMO to P. falciparum in vitro resulted in blockade of the cell cycle at the late trophozoite stage (3, 24, 25) , a stage in parasite development that may possibly be particularly sensitive to the effects of polyamine analogs. We have examined the effects of DFMO and MDL 27695 against asynchronous cultures ofP.falciparum (clone D6) and found that the drugs are merely additive rather than synergistic.
These polyamine analogs may additionally repress polyamine biosynthesis as do other polyamine analogs (10) . Depletion of polyamines by DFMO inhibits erythrocytic schizogony of P. falciparum in vitro (3, 4) and P. berghei in vivo (5), exoerythrocytic schizogony of P. berghei (26, 27) , and the sporogonous cycle in the mosquito vector (28) . Proc. Natl. Acad. Sci. USA 86 (1989) Therefore, repression of polyamine biosynthesis by our polyamine analogs might be a potential mechanism for slowing growth of the malaria parasite. However, exogenous putrescine, spermidine, or spermine did not reverse the growth inhibition caused by polyamine analogs either in vitro or in vivo (unpublished observations). This lack of reversal by the natural polyamines would be expected if the polyamine analogs block the intracellular binding of the polyamines or displace intracellular polyamines from their binding sites. Furthermore, inhibition of polyamine biosynthesis by DFMO generally results only in cytostasis rather than cell death (2), but the bis(benzyl)polyamine analogs seem to be cytotoxic.
Additionally, while Assaraf et al. (29) showed that incubation of P. falciparum in vitro with DFMO led to inhibition of DNA, RNA, and protein synthesis, these effects occurred relatively slowly. Inhibition followed a time course similar to that for depletion of polyamines by DFMO. In contrast, inhibition of P. falciparum DNA/RNA synthesis by MDL 27695 was apparently very rapid. Thus, while polyamine biosynthesis may be repressed by our polyamine analogs, we do not believe that this inhibition is the major toxic event in malaria parasites. Regardless of mechanism, the polyamine analogs represent an additional class of antimalarial drugs that may be useful for the chemotherapy of P. falciparum infections resistant to standard agents.
